Pursuant to Regulation 30, Regulation 51 and other applicable provisions of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the investor''s presentation with respect to Un-audited Financial Results for the first quarter ended on June 30, 2024.
Dear Sir, Pursuant to Regulation 30, Regulation 51 and other applicable provisions of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor''s Presentation with respect to Audited Financial Results for Quarter and Financial Year ended on March, 2024. The same is also available on the website of the Company i.e. www.polymedicure.com
Dear Sir/Madam, Please find enclosed the Investor Presentation covering the performance highlights of the Company for FY 2021-22. We have also uploaded the presentation on the Website of the Company at www.polymedicure.com We request you to take the above on record and the same be treated as the necessary compliance under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thanking You, Yours Sincerely
Dear Sir/Madam, Please find enclosed the Investor Presentation covering the performance highlights of the Company for FY 2020-21. We have also uploaded the presentation on the Website of the Company at www.polymedicure.com We request you to take the above on record and the same be treated as the necessary compliance under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Dear Sir/Madam, Please find enclosed the Investor Presentation covering the performance highlights of the Company for Q3 of FY 2020-21. We request you to take the above on record and the same be treated as the necessary compliance under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.